Literature DB >> 8496751

T cell activation and cytokine release in streptococcal toxic shock-like syndrome.

D Nadal1, R P Lauener, C P Braegger, A Kaufhold, B Simma, R Lütticken, R A Seger.   

Abstract

A 5-year-old girl with streptococcal toxic shock-like syndrome during varicella infection had high levels of tumor necrosis factor alpha and interleukin-6 but no interleukin-1 or interleukin-2 in the serum. Intravenous administration of gamma-globulin coincided with clinical improvement and with reduction of the levels of tumor necrosis factor alpha and interleukin-6. The data suggest that streptococcal pyrogenic exotoxins trigger synthesis of tumor necrosis factor alpha and interleukin-6 in vivo; intravenously administered gamma-globulin may down-regulate the cytokine response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496751     DOI: 10.1016/s0022-3476(06)80014-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

1.  Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Authors:  H Müller-Alouf; T Proft; T M Zollner; D Gerlach; E Champagne; P Desreumaux; C Fitting; C Geoffroy-Fauvet; J E Alouf; J M Cavaillon
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Therapeutic Approaches to Streptococcal Toxic Shock Syndrome.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

3.  Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics.

Authors:  C H Chiu; J T Ou; K S Chang; T Y Lin
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

4.  Toxic shock syndrome due to group C streptococci. A case report.

Authors:  S Natoli; C Fimiani; N Faglieri; L Laurenzi; A Calamaro; A M Frasca; E Arcuri
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

5.  Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.

Authors:  H Basma; A Norrby-Teglund; A McGeer; D E Low; O El-Ahmedy; J B Dale; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 6.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 7.  Streptococcal toxic shock syndrome in a postpartum woman. Case report and review of the literature.

Authors:  C Jorup-Rönström; M Hofling; C Lundberg; S Holm
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

8.  Beta-hemolytic streptococcal erythroderma syndrome: a clinical and pathogenic analysis.

Authors:  Harmony L Tyner; Patrick M Schlievert; Larry M Baddour
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

9.  Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

Authors:  Samir S Shah; Matthew Hall; Raj Srivastava; Anupama Subramony; James E Levin
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

10.  Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide.

Authors:  H Müller-Alouf; J E Alouf; D Gerlach; J H Ozegowski; C Fitting; J M Cavaillon
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.